세계의 스마트 인슐린 펜 및 펌프 시장 : 제품별, 사용성별, 용도별, 최종 용도별-예측(2025-2030년)

The Smart Insulin Pens & Pumps Market was valued at USD 1.38 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 9.89%, to USD 2.68 billion by 2030.

The smart insulin pens and pumps market is a rapidly evolving sector within the diabetes management industry, focused on providing advanced and digitally enhanced devices for insulin delivery. These devices integrate technology to offer improved insulin management through features like precise dosing, data tracking, and connectivity to healthcare apps. The necessity for such innovations is primarily driven by the escalating prevalence of diabetes worldwide, the demand for efficient management solutions, and the increasing focus on personalized medicine. In terms of application, smart insulin pens and pumps serve individuals with Type 1 and Type 2 diabetes, providing them with user-friendly tools that enhance adherence and contribute to better glycemic control. The end-use scope extends from individual patients to healthcare providers who seek to optimize diabetes care with real-time data and telehealth capabilities.

Key growth drivers in this market include technological advancements, the rise of telemedicine, and supportive government policies promoting digital healthcare adoption. Potential opportunities lie in expanding the accessibility of these devices, especially in emerging markets, fostering collaborations with tech companies for increased device connectivity, and developing more affordable options to increase market penetration. Challenges include the high cost of technology, regulatory hurdles, and data privacy concerns that could hinder widespread adoption. Innovations that could drive business growth include further integration with artificial intelligence for predictive analytics, development of smaller and more discreet devices, and improvements in user interface design for enhanced patient engagement. The competitive landscape is characterized by strong R&D investments and strategic partnerships aimed at expanding product portfolios and geographical reach. The market's nature is dynamic, with a trend towards personalized and patient-centric solutions, demanding ongoing innovation to address limitations such as battery life and device accuracy. Companies focused on addressing these challenges while expanding access and reducing costs are well-positioned to capitalize on emerging trends and opportunities within the smart insulin pens and pumps sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Insulin Pens & Pumps Market

The Smart Insulin Pens & Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness of diabetic management tools
  • Rising preference for homecare settings among the geriatric populace
  • Ongoing shift towards digital health solutions and telemedicine supports
• Market Restraints
  • Capital-intensive smart insulin devices and concerns over product recalls
• Market Opportunities
  • Technology advancements in smart insulin devices offer connectivity with mobile applications and cloud storage
  • Emerging products with customization of devices to achieve personal goals for diabetic
• Market Challenges
  • Concerns regarding privacy and security of health data collected and transmitted by smart devices

Porter's Five Forces: A Strategic Tool for Navigating the Smart Insulin Pens & Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Insulin Pens & Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Insulin Pens & Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Insulin Pens & Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Insulin Pens & Pumps Market

A detailed market share analysis in the Smart Insulin Pens & Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Insulin Pens & Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Insulin Pens & Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Insulin Pens & Pumps Market

A strategic analysis of the Smart Insulin Pens & Pumps Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Insulin Pens & Pumps Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Bigfoot Biomedical, Inc., Biocon Ltd., Debiotech SA, Eli Lilly and Company, Emperra GmbH, F. Hoffmann-La Roche Ltd., Haselmeier GmbH, Insulet Corporation, Johnson & Johnson Services Inc., Medtronic PLC, Medtrum Technologies Inc., NIPRO EUROPE GROUP COMPANIES, Novo Nordisk A/S, Owen Mumford Limited, pendiq GmbH, Sanofi S.A., SOOIL Development Co., Ltd., Tandem Diabetes Care, Inc., Terumo Group, Wockhardt Limited, and Ypsomed Holding.

Market Segmentation & Coverage

This research report categorizes the Smart Insulin Pens & Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Smart Insulin Pens and Smart Insulin Pumps. The Smart Insulin Pens is further studied across First Generation Pens and Second Generation Pens. The Second Generation Pens is further studied across Bluetooth-Enabled and USB Connected.
• Based on Usability, market is studied across Prefilled and Reusable.
• Based on Application, market is studied across Type I Diabetes and Type II Diabetes.
• Based on End-Use, market is studied across Homecare, Hospitals & Clinics, and Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness of diabetic management tools
    • 5.1.1.2. Rising preference for homecare settings among the geriatric populace
    • 5.1.1.3. Ongoing shift towards digital health solutions and telemedicine supports
  • 5.1.2. Restraints
    • 5.1.2.1. Capital-intensive smart insulin devices and concerns over product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Technology advancements in smart insulin devices offer connectivity with mobile applications and cloud storage
    • 5.1.3.2. Emerging products with customization of devices to achieve personal goals for diabetic
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding privacy and security of health data collected and transmitted by smart devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning adoption of bluetooth-enabled smart insulin pens supports more detailed tracking and management of one's insulin therapy
  • 5.2.2. End-Use: Evolving usage of smart insulin pens and pumps in hospitals and clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Smart Insulin Pens & Pumps Market, by Product

• 6.1. Introduction
• 6.2. Smart Insulin Pens
  • 6.2.1. First Generation Pens
  • 6.2.2. Second Generation Pens
    • 6.2.2.1. Bluetooth-Enabled
    • 6.2.2.2. USB Connected
• 6.3. Smart Insulin Pumps

7. Smart Insulin Pens & Pumps Market, by Usability

• 7.1. Introduction
• 7.2. Prefilled
• 7.3. Reusable

8. Smart Insulin Pens & Pumps Market, by Application

• 8.1. Introduction
• 8.2. Type I Diabetes
• 8.3. Type II Diabetes

9. Smart Insulin Pens & Pumps Market, by End-Use

• 9.1. Introduction
• 9.2. Homecare
• 9.3. Hospitals & Clinics
• 9.4. Laboratories

10. Americas Smart Insulin Pens & Pumps Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Smart Insulin Pens & Pumps Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Smart Insulin Pens & Pumps Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Tandem Diabetes Care Launches Tandem Mobi, the World's Smallest, Durable Automated Insulin Delivery System
  • 13.3.2. Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People With Diabetes
  • 13.3.3. Innovation Zed wins CE mark for insulin pen add-on device
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Melsungen AG
• 2. Becton, Dickinson and Company
• 3. Bigfoot Biomedical, Inc.
• 4. Biocon Ltd.
• 5. Debiotech SA
• 6. Eli Lilly and Company
• 7. Emperra GmbH
• 8. F. Hoffmann-La Roche Ltd.
• 9. Haselmeier GmbH
• 10. Insulet Corporation
• 11. Johnson & Johnson Services Inc.
• 12. Medtronic PLC
• 13. Medtrum Technologies Inc.
• 14. NIPRO EUROPE GROUP COMPANIES
• 15. Novo Nordisk A/S
• 16. Owen Mumford Limited
• 17. pendiq GmbH
• 18. Sanofi S.A.
• 19. SOOIL Development Co., Ltd.
• 20. Tandem Diabetes Care, Inc.
• 21. Terumo Group
• 22. Wockhardt Limited
• 23. Ypsomed Holding